Insider filing · NAMS
NAP B.V. ForGrowth
10% owner
profile →
NewAmsterdam Pharma Company N.V.
NAMS · Healthcare · 45 filings in 24 months
ticker →
NAP B.V. ForGrowth sold $4.1M of NewAmsterdam Pharma (NAMS)
Executed Dec 18 2024, disclosed Dec 20 2024, 2 days later.
Value, as filed
$4.1M
157,234 sh across 3 lots
Executed
Dec 18 2024
the trade date, as filed
Disclosed
Dec 20 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NFNAP B.V. ForGrowth (10% owner) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $4.1M of NAMS (157,234 sh across 3 lots, as filed), executed Dec 18 2024.
The name
NAMSHealthcare · NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with ca…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by NAP B.V. ForGrowth in NAMS
NAMSSALE
NewAmsterdam Pharma Company N.V.
$762K29,846 sh × $25.54
Exec Dec 30 2024
Filed Jan 2 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. $1.0M
41,803 sh across 2 lots
Exec Nov 15 2024
Filed Nov 19 2024 · 5:30 PM ET